Radu Bogdan Mateescu, Cristian Gheorghe, Anca Victorita Trifan, Adrian Saftoiu, Andrada Seicean, Mihai Mircea Diculescu, Christian Banciu, Liliana Simona Gheorghe, Bogdan Busuioc, Adrian Goldis, Daniela Dobru, Ovidiu Fratila, Dumitru Eugen, Simona Bataga, Gabriel Constantinescu, Dan Gheonea, Alina Tantau, Mariana Jinga, Ciprian Brisc, Cristina Cijevschi Prelipcean, Romeo Chira, Carmen Fierbințeanu-Braticevici, Dan Dumitrascu, Monica State, Theodor Voiosu, Lucian Negreanu
BACKGROUND AND AIMS: Real-world assessments of efficacy and safety of advanced therapies used for inflammatory bowel disease (IBD) patients are limited. We aimed to report safety, efficacy and treatment persistence of new molecules (infliximab, adalimumab, vedolizumab, tofacitinib, ustekinumab) in a retrospective multicentric national Romanian analysis. METHODS: We conducted a nationwide, retrospective observational multicentric study. Data were collected retrospectively from electronic and paper files...
December 22, 2023: Journal of Gastrointestinal and Liver Diseases: JGLD